Atlas Trials

Study of Oncolytic Virus in Combination With HX-008 and Radiotherapy in Melanoma Patients With Liver Metastasis

Clinical trial NCT05068453 · UNKNOWN

Trial details

NCT number
NCT05068453
Sponsor
Peking University Cancer Hospital & Institute
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Melanoma Stage IV
Start date
2021-10-01
Primary completion
2023-10-31
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.